- Abstract Number: 0314
Lack of Systemic Effects from Intra-articular XT-150 for the Treatment of Moderate to Severe Pain Due to OA of the Knee: Safety Results from a Phase 2 Trial
- Abstract Number: 2387
Large Vessel Involvement and the Risk of Severe Infections in Patients with Giant Cell Arteritis – a Population-based Study
- Abstract Number: 1538
Large Vessel Involvement in Antineutrophil Cytoplasmic Antibody- Associated Vasculitis: A Single Center Experience over Two Decades
- Abstract Number: 0702
Large Vessel Vasculitis Increases Risk of Acute Myocardial Infarction in Patients Admitted for Congestive Heart Failure : A Nationwide Inpatient Database Study
- Abstract Number: 2513
Latent Class Analysis Identifies 2 Clinical Phenotypes of Immune Checkpoint Inhibitor-induced Inflammatory Arthritis
- Abstract Number: 0388
Left Ventricular Geometry Abnormalities Are Related to Higher Clinical Activity in Rheumatoid Arthritis Patients
- Abstract Number: 0812
Length of Synovial Fluid Monosodium Urate Crystals According to Sonographic Articular Deposits: Advancing in the Crystallization Process
- Abstract Number: 2099
Lesser Impact of Lower-Small Joint Involvement on Pain Than Upper-Small Joint in Rheumatoid Arthritis: Analysis Based on a Large Rheumatoid Arthritis Database in Japan
- Abstract Number: 0147
Leukotriene Inhibitors Effect on Post-Traumatic Osteoarthritis: A Real-World Evidence Comparative Effectiveness Study
- Abstract Number: 0494
Levels of Atherosclerotic Index of Plasma and Triglyceride Glucose Index in Patients with Psoriatic Arthritis and Carotid Plaque
- Abstract Number: 2324
Leveraging ChatGPT for Real-World Systematic Lupus Erythematosus Data Curation from Electronic Health Records: A Feasibility Study
- Abstract Number: 1012
Leveraging Cues and Rewards to Form Habits to Improve Medication Adherence in Gout: An Adaptive Behavioral Pilot Trial
- Abstract Number: 0196
Limited Regulatory T Cell Response in Post-Chikungunya Viral Arthritis: A Therapeutic Opportunity?
- Abstract Number: 2137
Line of Therapy of Biologics and JAK Inhibitors in RA, PsA and AxSpA: Implications for Design and Uptake of New Drugs and Diagnostics
- Abstract Number: 0895
Lipocalin-2 Promotes Cutaneous and Neuropsychiatric Disease in Murine Lupus
- Abstract Number: 0598
Litifilimab Modulates Type I IFN Biomarkers in Patients with SLE or CLE in the Phase 2 LILAC Study
- Abstract Number: 0762
Liver Disease Is a Common Feature of HA20 That Causes Significant Morbidity Associated with Interferon Induction
- Abstract Number: 0801
LncRNA PIGL-217 Regulates Th17 Differentiation by Targeting miR-5008-5p and Suppressing FoxO1 in Behçet’s Disease
- Abstract Number: 1250
Local Inflammatory Response Mediated by the Homing of Tfh17 Cells Is Involved in Tissue Injury of Immunoglobulin a Vasculitis
- Abstract Number: 0152
Long Covid in Persons with Self-Reported Arthritis – Symptoms, Associated Factors and Functional Limitations
- Abstract Number: 0588
Long Term Safety and Predictors of Serious Infections Among Patients with Systemic Lupus Erythematosus Treated with Rituximab: Audit from a Single Center Biologic Registry
- Abstract Number: 0355
Long Term Safety of Drugs in Systemic Juvenile Idiopathic Arthritis
- Abstract Number: 1383
Long-term Association Between Physical Activity and Global Functioning in Patients with axSpA: Results of a 2 Year Prospective Study
- Abstract Number: 1165
Long-term Changes in Lung Function in Melanoma Differentiation-associated Protein 5 (MDA5) Antibody Positive Dermatomyositis Patients: Experience of a Single Center Longitudinal Cohort in North America
- Abstract Number: 0451
Long-term Clinical Profile of Filgotinib in Patients with Rheumatoid Arthritis by Cardiovascular Risk Factors: A Post Hoc Subgroup Analysis
- Abstract Number: 0317
Long-term Effectiveness of a Lifestyle Program for Osteoarthritis: One-year Follow-up of the “Plants for Joints” Randomized Clinical Trial
- Abstract Number: 1331
Long-term Effectiveness of a Lifestyle Program for Rheumatoid Arthritis: One-year Follow-up of the “Plants for Joints” Randomized Clinical Trial
- Abstract Number: 2166
Long-Term Effects of Abatacept on Arthritis and Atherosclerosis in Older vs Younger Patients with Rheumatoid Arthritis: 3-year Results of a Prospective, Multicenter, Observational Study
- Abstract Number: 1572
Long-term Efficacy and Retention Rate of Molecular Targeted Drugs in Takayasu Arteritis
- Abstract Number: 1434
Long-Term Efficacy and Safety of Risankizumab for Active Psoriatic Arthritis: 148-Week Results from the KEEPsAKE 2 Trial
- Abstract Number: 1435
Long-Term Efficacy and Safety of Risankizumab for CsDMARD-IR Patients with Active Psoriatic Arthritis: 148-Week Results from the KEEPsAKE 1 Trial
- Abstract Number: 1868
Long-term Efficacy of a 2-year MRI Treat-to-target Strategy on Radiographic Joint Damage Progression in Rheumatoid Arthritis Patients in Clinical Remission – Five Year Follow-up of the IMAGINE-RA Randomized Clinical Trial
- Abstract Number: 0854
Long-term Efficacy of Remission-induction Regimens for Eosinophilic Granulomatosis with Polyangiitis
- Abstract Number: 2225
Long-term Evolution of Spondyloarthritis Patients Included in REGISPONSER, 17 Years Later (REGISPON-3 Study)
- Abstract Number: 1273
Long-term Follow-up of Treated-to-target RA and UA: Results of the BeSt and IMPROVED Studies
- Abstract Number: 1850
Long-term Glucocorticoid Use in a Cohort of Elderly Early Rheumatoid Arthritis Patients: A Joint Analysis of Medicare and the Rheumatology Informatics System for Effectiveness (RISE) Data
- Abstract Number: 1537
Long-term Observational Study of Interstitial Lung Disease in ANCA-associated Vasculitis
- Abstract Number: 0307
Long-term Prognosis and Recurrence in anti-MDA-5 Antibody-positive Dermatomyositis
- Abstract Number: 0519
Long-Term Safety and Efficacy of Bimekizumab in Patients with Active Ankylosing Spondylitis: 5-Year Results from a Phase 2b Study and Its Open-Label Extension
- Abstract Number: 1505
Long-term Safety and Efficacy of Voclosporin in Black Patients with Lupus Nephritis: Results from the AURORA 1 and AURORA 2 Studies
- Abstract Number: 0511
Long-term Safety and Tolerability of Bimekizumab in Patients with Axial Spondyloarthritis and Psoriatic Arthritis: Results from Pooled Phase 2b/3 Studies
- Abstract Number: 1422
Long-Term Safety of Risankizumab in Patients with Psoriatic Disease: Integrated Analysis of Psoriasis and Psoriatic Arthritis Clinical Trial Data
- Abstract Number: 0679
Long-term Safety of Rituximab (Mabthera) in Granulomatosis with Polyangiitis (GPA) or Microscopic Polyangiitis (MPA): Rituximab Surveillance Study in VASculitis (RIVAS)
- Abstract Number: 0425
Long-term Safety of Rituximab in Rheumatoid Arthritis: A Systematic Review and Meta-analysis
- Abstract Number: 1533
Long-term Use of Rituximab in Systemic Sclerosis: A Real-life Italian Multicentre Study
- Abstract Number: 2325
Longitudinal ANA Titers in SLE and ANA-associated Rheumatic Diseases
- Abstract Number: 1229
Longitudinal Assessment of Self-reported Executive Function in Youth with Childhood-Onset Lupus
- Abstract Number: 1805
Longitudinal Changes in Serum Urate Associate Minimally with Changes in Daily Alcohol Intake
- Abstract Number: 2271
Longitudinal Changes in Type 1 & Type 2 SLE Activity
- Abstract Number: 2238
Longitudinal Effect of Guselkumab on Biomarkers of Inflammation and Cardiovascular Risk in Bionaive Patients with Active Psoriatic Arthritis and High Systemic Inflammatory Burden: Post-hoc Analysis of a Phase 3, Randomized, Double-blind, Placebo-Controlled Study
- Abstract Number: 0557
Longitudinal Evaluation of Cell-bound Complement Activation Products in Patients with SLE
- Abstract Number: 1429
Longitudinal Evaluation of the Novel Psoriatic Arthritis 5-Thermometer Scale (PsA-5Ts) Domains During Treatment with Guselkumab: Pooled Analysis of Three Phase 3, Randomized, Double-blind, Placebo-Controlled Studies
- Abstract Number: 0339
Longitudinal Glucocorticoid Toxicity in Rheumatic Disease Patients (LONG-TOX) and Associations with Quality of Life and Healthcare Resource Utilization: Interim Analysis from a Prospective Cohort
- Abstract Number: 2433
Longitudinal Multi-Omics Single Cell Analysis Reveals Abatacept Treatment Shifts Peripheral Lymphocyte Subpopulations in Seropositive RA with Reduction of Mature B Cells and Retention of Transitional and Naive B Cells
- Abstract Number: 1718
Longitudinal Quantification of Bone Erosions, Pulmonary Disease, Pain, Gait and Sarcopenia to Holistically Assess Decreased Ad Libitum Physical Activity and Effects of Exercise in the TNF-Transgenic Murine Model of Rheumatoid Arthritis
- Abstract Number: 0210
Longitudinal T Cell Responses to a Series of Four SARS-CoV-2 Vaccine Doses or COVID-19 in Patients on TNF Inhibitors
- Abstract Number: 2378
Longitudinal Trajectories of Renal Function in ANCA-Associated Vasculitis: Findings from the Expanded Mass General Brigham Cohort
- Abstract Number: 0230
Looking Beyond Infections in Job Syndrome: Peripheral Calcium Pyrophosphate Deposition Disease in a Cohort of Patients with Job Syndrome
- Abstract Number: 0001
Loss of the Complement Regulator CD55 Alters Marginal Zone B Cell Homeostasis
- Abstract Number: 0877
Loss of Transient Receptor Potential Channel 1 (TRPC1) Links Regulation of Intracellular Calcium to Cellular Senescence and Leads to Development of Osteoarthritis
- Abstract Number: 0842
Low Rate of Switching from Nr-axSpA to r-axSpA After 10 Years of Follow up in Early Axialspondyloarthritis. Data from DESIR Cohort
- Abstract Number: 2470
Low Serum Adiponectin Levels Were Associated with Radiographic Progression of Hand Osteoarthritis in a 6-year Follow-up of the Dong-gu Study
- Abstract Number: 1389
Low Spinal Radiographic Progression After a Mean of 15 Years of Follow-up in a Cohort of Patients with Axial Spondyloarthritis
- Abstract Number: 2548
Low Uveitis Rates in Patients with Axial Spondyloarthritis Treated with Bimekizumab: Pooled Results from Phase 2b/3 Trials
- Abstract Number: 0781
Low vs. High Initial Oral Glucocorticoid Dose for Lupus Nephritis Induction Treatment: A Pooled Analysis of Randomized Controlled Clinical Trials
- Abstract Number: 0905
Low-Density Granulocytes and Neutrophil Extracellular Traps in Incomplete Systemic Lupus Erythematosus
- Abstract Number: 1267
Lower Herpes Zoster Rate of Tocilizumab and Tofacitinib in Patients Undergoing Treatment for Rheumatoid Arthritis
- Abstract Number: 1022
Lower Rates of Statin Therapy Initiation in Dermatomyositis/Polymyositis vs. Rheumatoid Arthritis Patients with Hyperlipidemia: A Multicenter USA-Based Study (2018-2023)
- Abstract Number: 2188
Lung Cysts in Primary SS: New Findings on an Allegedly Innocuous Iiagnosis
- Abstract Number: 2265
Lupus Damage Index Revision – Item Generation and Reduction Phase
- Abstract Number: 1464
Lupus Flares More Common in Patients on Dialysis Compared to After Renal Transplant: A Systematic Review and Meta-analysis
- Abstract Number: 1501
Lupus Low Disease Activity State (LLDAS) Achievement with Deucravacitinib, an Oral, Selective, Allosteric Tyrosine Kinase 2 Inhibitor, in a Phase 2 Trial in SLE
- Abstract Number: 2275
Lupus Low Disease Activity State Ameliorates the Poor Prognosis in Lupus Nephritis Patients with anti-Sm Autoantibody
- Abstract Number: 2274
Lupus Low Disease Activity State as an Attainable Target in Lupus Nephritis Associated with Reduced Risk of Relapse
- Abstract Number: 0851
Lupus Nephritis Flares Linked to Platelet Activation During Gut Pathobiont Blooms
- Abstract Number: 2017
Lupus Nephritis Is Strongly Associated with Low Bone Mineral Density and Osteoporosis in Patients with Systemic Lupus Erythematosus
- Abstract Number: 0593
Lupus Nephritis of the Spanish National Registry of Belimumab in Patients with Systemic Lupus Erythematosus
- Abstract Number: 2456
Lupus Patient Navigator Program to Improve Healthcare Barriers for Minority Patients
- Abstract Number: 1652
Lupus Research Action Network: Increasing Minority Clinical Trial Participation Through Peer Leaders
- Abstract Number: PP03
Lupus with Slime: Improve QOL and Increase ROM in SLE with Slime
- Abstract Number: 0255
Lymphoid Mass in the Inferior Turbinate with IgG4 Producing Cells: A Nasal Manifestation of IgG4-RD or a Distinct Chronic Inflammatory Disease?
- Abstract Number: 2189
Lymphopenia Fluctuation Patterns Determine the Trajectory of the Disease in Sjogren’s Patients with Hematological Involvement
ACR Convergence 2023
November 10-15, 2023. San Diego, CA.